← Open Payments lookup

ELIZABETH COULSON: Open Payments

NPI 1487251930 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$365 in 19 payments from 11 companies in 2025. Trend: 2023 $146 · 2024 $363 · 2025 $365

Food & beverage: $365
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$74
Gilead Sciences, Inc.3$67
E.R. Squibb & Sons, L.L.C.2$37
Luye Pharma (USA) Ltd.2$33
ABBVIE INC.2$31
Neurocrine BioSciences, Inc.1$25
ViiV Healthcare Company1$24
Lilly USA, LLC1$21
Alkermes, Inc.1$21
Indivior Inc.1$16

Products named: REXULTI, COBENFY, ERZOFRI EXTENDED-RELEASE, INGREZZA, APRETUDE, MOUNJARO, ARISTADA, ABILIFY MAINTENA.

Industry payments across IN — which companies pay providers there.